| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/07/2009 | US7514572 Spiro ortho ester-ether-substituted furocoumarins derived from citrus fruits, especially grapefruit; nontoxic |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2341968C Pyrrolobenzodiazepine compounds |
| 04/07/2009 | CA2341471C Pyrrolbenzodiazepines |
| 04/02/2009 | WO2009040556A1 Pyrimidine derivatives as protein kinase inhibitors |
| 04/02/2009 | US20090088570 Organic electroluminescent device |
| 04/02/2009 | US20090088568 Vinorelbine derivatives |
| 04/02/2009 | CA2700979A1 Pyrimidine derivatives as protein kinase inhibitors |
| 04/01/2009 | EP2042504A1 Fused azole-pyrimidine derivatives |
| 04/01/2009 | EP2041145A1 Azatricyclic compounds and their use |
| 04/01/2009 | EP2041138A2 Pyrrolotriazine kinase inhibitors |
| 04/01/2009 | EP2041132A2 New compounds |
| 04/01/2009 | EP2041131A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 04/01/2009 | CN101400674A Antibiotic compounds |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | US20090082571 Intermediates of 2-substituted carbapenem derivatives and process for production thereof |
| 03/26/2009 | US20090079343 Organic electroluminescent device |
| 03/26/2009 | CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038263A1 Novel aromatic aza heterocycles, method of production and use of the material in organic electronics |
| 03/25/2009 | EP1504010B1 Vitamin-mitomycin conjugates |
| 03/25/2009 | CN100471858C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 03/24/2009 | US7507840 Nonlinear optically active compounds that include a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge |
| 03/24/2009 | US7507826 Such as 3-(2-Methanesulfonyl-pyrimidin-4-yl)-5-pyridin-3-yl-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine; heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, destructive bone disorders |
| 03/24/2009 | US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 03/24/2009 | CA2348579C Azadirachtin compounds extracted from azadirachta indica, compositions and use thereof as insecticidal |
| 03/19/2009 | WO2009034169A1 Processes for the preparation of the alpha crystal polymorph of metal phthalocyanines |
| 03/19/2009 | WO2009033581A1 Substituted tricyclic compounds and methods of use thereof |
| 03/19/2009 | WO2008051552A3 Organic semiconductor materials and methods of preparing and use thereof |
| 03/19/2009 | US20090076200 Letter with continuation application |
| 03/18/2009 | EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 03/18/2009 | EP2035436A1 Fused thiazole derivatives as kinase inhibitors |
| 03/18/2009 | EP1575960B1 1,4-diazabicyclo 3.2.2 nonanecarboxamide derivatives, preparation and therapeutic use thereof |
| 03/18/2009 | EP1569936B1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 03/18/2009 | CN101389634A Fluorine-containing compound and method for producing same, fluorine-containing polymer, organic thin film, and organic thin film device |
| 03/18/2009 | CN101386625A Vinflunine derivates and preparation method thereof and application thereof in preparing medicament for targeted therapy solid tumors, liver cancer or lung cancer |
| 03/18/2009 | CN101386624A Vinflunine arginine ester and preparation method thereof and thereof application in preparing medicament for targeted therapy solid tumors and cancer |
| 03/17/2009 | US7504507 carboxamide linked compounds based on benzo[b][1,6]naphthyridin-1 (2H)-one, which differ from previous acridine based compounds by the incorporation of a lactam or thiolactam function in one of the outer rings |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/12/2009 | WO2008125945A3 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c |
| 03/11/2009 | EP2032585A2 Substituted pteridines as therapeutic agents |
| 03/11/2009 | EP2032583A1 New chemical compounds |
| 03/11/2009 | EP1919475B1 Tetrahydro- beta-carbolin-sulfonamide derivatives as 5-ht6 ligands |
| 03/11/2009 | EP1499622B1 Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/11/2009 | EP1165564B1 Process for preparing inhibitors of nucleoside metabolism |
| 03/11/2009 | CN101384605A Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 03/11/2009 | CN101384258A FGF-peceptor agonist dimeric compounds |
| 03/10/2009 | US7501523 reacting an oligomer consisting of 2-11 linked glycolurils or analogues with one or more compounds selected from glycoluril, glycoluril analogues and/or oligomers of glycoluril or glycoluril analogues, in the presence of an acid, and a template (dimethylaminobenzaldehyde) to form a cucurbit(n)uril |
| 03/10/2009 | US7501433 Opioid and opioid-like compounds and uses thereof |
| 03/10/2009 | US7501076 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance |
| 03/10/2009 | CA2468649C Adenosine a2a receptor antagonists |
| 03/10/2009 | CA2285263C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 03/04/2009 | EP2029612A1 Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials |
| 03/04/2009 | EP2029575A1 Substituted spirocyclic cgrp receptor antagonists |
| 03/04/2009 | EP1392312B1 TRIAZOLO 4,5-d PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
| 03/04/2009 | CN101379062A 3,9-diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054416 1,4-Diazabicyclo[3.2.2]nonanecarboxamide Derivatives, Preparation and Therapeutic Use Thereof |
| 02/25/2009 | EP1668017B1 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 02/25/2009 | CN101374845A Novel compounds and use thereof |
| 02/25/2009 | CN101374843A Triazolopyridazines as tyrosine kinase modulators |
| 02/25/2009 | CN101374839A Azaindoles useful as inhibitors of janus kinases |
| 02/25/2009 | CN101374838A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors |
| 02/24/2009 | US7495003 e.g. 1-(naphthyl-1-ylmethyl)-3-(methoxycarbonylmethyl)-7-(but-2-ynyl)-8-(3-amino-piperidin-1-yl)-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 02/24/2009 | US7495002 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
| 02/24/2009 | US7494991 For microbial infections specially Gram-positive bacterial infection; atherosclerosis-associated disease |
| 02/19/2009 | WO2009023487A1 Tetracyclic compounds for the treatment of hepatitis c |
| 02/19/2009 | US20090048244 Pyrrolotriazine compounds as kinase inhibitors |
| 02/19/2009 | US20090047692 Optically-detectable enzyme substrates and their method of use |
| 02/18/2009 | EP2024375A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 02/18/2009 | EP2024358A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/18/2009 | CN101369633A Pyran derivative |
| 02/18/2009 | CN101367802A Beta-kabarin alkaloids in quassia wood, preparation method and application thereof |
| 02/17/2009 | US7491716 Glycogen synthase kinase-3 inhibitors such as [1-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-6,7-dihydro-6H-[1,4]diazepino[6,7,1-hi]indol-6-yl]-[morpholin-4-yl]methylenecyanamide, used for treating diabetes, Alzheimer's disease and for stimulating bone deposition in mammals |
| 02/17/2009 | US7491714 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 02/17/2009 | CA2316474C Stabilizer mixtures |
| 02/12/2009 | WO2009019286A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 02/12/2009 | CA2691529A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 02/11/2009 | EP2022793A1 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 02/11/2009 | EP1605938B1 Antibacterial derivatives of napthydrin and quinoline |
| 02/11/2009 | CN101362771A Method for preparing high purity vincristine sulfate |
| 02/05/2009 | WO2009017236A1 Pyridopyrimidin-4-one derivatives |
| 02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | US20090036443 6-cyclohexyl-5-phenyl-4H-thieno[3,2-b]pyrrole-2-carboxylic acid, used for inhibiting hepatitis C virus polymerase or prevention and treatment of hepatitis C viral infections |
| 02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/04/2009 | EP2019671A2 Bivalent smac mimetics and the uses thereof |
| 02/04/2009 | EP2019592A1 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer |
| 02/04/2009 | CN101360748A Inhibitors of c-met and uses thereof |
| 02/04/2009 | CN101357929A Cephalosporin derivative containing sulfhydryl thiadiazole |
| 02/04/2009 | CN101357917A Carbapenem compound containing formyl hydrazino |
| 02/04/2009 | CN100457760C Preparation method of ertabeinan sodium salt |
| 02/04/2009 | CN100457757C Novel spiro compounds |
| 02/03/2009 | US7485634 Methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of |
| 02/03/2009 | US7485442 Incubating a mixture comprising a target sequence, oligonucleotide primers complementary to regions of target sequence, a polymerizing enzyme, nucleotide substrates, and an oligonucleotide conjugate linked to a fluorophore; replication and amplification; continuously monitoring fluorescence produced |